A Belgian cell therapy startup has found success by partnering with Chinese companies. EsoBiotec, which started the year with just 12 employees and €22 million in funding, is now looking to expand its operations after adopting a unique approach to testing novel therapies – a method pioneered by China’s low-cost biotech industry.
Source: https://endpoints.news/western-genetic-medicine-makers-turn-to-chinese-investigator-initiated-trials